Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis-Reference-Cited by-同舟云学术

Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis

Published:2020-04-20 Issue:4 Volume:15 Page:e0230959
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sauri-Suárez Sergio,Quiñones-Aguilar Sandra,Contreras-Marín Arturo,Ramiro-Guerrero Erik Omar,Zúñiga-García David,Salinas-Vázquez Leticia,Llamas-López Leonardo,León-Jiménez Carolina,García-Martell Adriana,González-Hernández Iliana,Chiquete Erwin,García Silvia^ORCID

Funder

Merck Mexico

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Multiple Sclerosis

2. Burden and cost of multiple sclerosis in Brazil;G Kobelt;PLoS One,2019

3. Evolution of multiple sclerosis prevalence and phenotype in Latin America;L Negrotto;Mult Scler Relat Disord,2018

4. Patient preferences for Interferon-beta in Iran: A discrete choice experiment;F Rahimi;PLoS One,2018

5. Adherence to Disease-Modifying Therapies for Multiple Sclerosis;L Higuera;J Manag Care Spec Pharm,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation;Expert Review of Clinical Immunology;2023-09-11

2. Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years;Expert Opinion on Drug Delivery;2023-06-03

3. The Quality of Life and Medication Adherence in Patients with Multiple Sclerosis—Cross-Sectional Study;International Journal of Environmental Research and Public Health;2022-11-05

4. Effects of disease-modifying treatments discontinuation in patients with relapsing-remitting multiple sclerosis: A 5 year prospective cohort study;Multiple Sclerosis and Related Disorders;2022-07

5. Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study;Frontiers in Neurology;2021-02-24